These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29937051)

  • 1. CRISPR-Based Technologies for Metabolic Engineering in Cyanobacteria.
    Behler J; Vijay D; Hess WR; Akhtar MK
    Trends Biotechnol; 2018 Oct; 36(10):996-1010. PubMed ID: 29937051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering tools in model cyanobacteria.
    Carroll AL; Case AE; Zhang A; Atsumi S
    Metab Eng; 2018 Nov; 50():47-56. PubMed ID: 29588234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered CRISPR/Cas9 system for multiplex genome engineering of polyploid industrial yeast strains.
    Lian J; Bao Z; Hu S; Zhao H
    Biotechnol Bioeng; 2018 Jun; 115(6):1630-1635. PubMed ID: 29460422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
    Naduthodi MIS; Barbosa MJ; van der Oost J
    Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in genetic engineering tools based on synthetic biology.
    Ren J; Lee J; Na D
    J Microbiol; 2020 Jan; 58(1):1-10. PubMed ID: 31898252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical Review of Genome Editing and Synthetic Biology Applications in Metabolic Engineering of Microalgae and Cyanobacteria.
    Ng IS; Keskin BB; Tan SI
    Biotechnol J; 2020 Aug; 15(8):e1900228. PubMed ID: 32080963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas mediated genome engineering of cyanobacteria.
    Sengupta A; Liu D; Pakrasi HB
    Methods Enzymol; 2022; 676():403-432. PubMed ID: 36280360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR interference as a titratable, trans-acting regulatory tool for metabolic engineering in the cyanobacterium Synechococcus sp. strain PCC 7002.
    Gordon GC; Korosh TC; Cameron JC; Markley AL; Begemann MB; Pfleger BF
    Metab Eng; 2016 Nov; 38():170-179. PubMed ID: 27481676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of the cyanobacterial CRISPR-Cas systems and development of the synthetic CRISPR-Cas systems for cyanobacteria.
    Pattharaprachayakul N; Lee M; Incharoensakdi A; Woo HM
    Enzyme Microb Technol; 2020 Oct; 140():109619. PubMed ID: 32912679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-Art Genetic Modalities to Engineer Cyanobacteria for Sustainable Biosynthesis of Biofuel and Fine-Chemicals to Meet Bio-Economy Challenges.
    Khan AZ; Bilal M; Mehmood S; Sharma A; Iqbal HMN
    Life (Basel); 2019 Jun; 9(3):. PubMed ID: 31252652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photomixotrophic chemical production in cyanobacteria.
    Matson MM; Atsumi S
    Curr Opin Biotechnol; 2018 Apr; 50():65-71. PubMed ID: 29179151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of Industrial Chemicals from CO
    Zhou J; Meng H; Zhang W; Li Y
    Adv Exp Med Biol; 2018; 1080():97-116. PubMed ID: 30091093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-derived genome editing technologies for metabolic engineering.
    Nishida K; Kondo A
    Metab Eng; 2021 Jan; 63():141-147. PubMed ID: 33307189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
    Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
    Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and metabolic advances in the engineering of cyanobacteria.
    Vijay D; Akhtar MK; Hess WR
    Curr Opin Biotechnol; 2019 Oct; 59():150-156. PubMed ID: 31238294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.